News & Blog

Phase III Brain Tumor Clinical Trials Open for Patient Enrollment – July 2019 Update

Below is a list of phase III clinical trials that are currently open for primary brain tumor patients in the United States.

phase III clinical trial is traditionally the last, pivotal step in the evaluation of a potential new medicine before it is approved for use by all patients with the indicated disease.

Many of these are trials of a “novel/investigational agent” – meaning it is the first time a particular treatment is being tried for brain tumor patients. There are also a number of trials with therapies already in use for some brain tumor patients, which researchers are evaluating in different combinations, different dosing regimens, and/or specific subgroups of patients.

Phase III Clinical Trials with Novel/Investigational Agents

Phase III Clinical Trials with Prior/Known Agents


For a more comprehensive list of ALL open brain tumor clinical trials, please visit the NBTS Clinical Trial Finder at trials.braintumor.org, where you can search potential opportunities for enrollment based on criteria important and specific to you.

*Image courtesy of the National Cancer Institute of the National Institutes of Health (cancer.gov)

Post a Comment

Your email is kept private. Required fields are marked *

Share